IGM Biosciences (Nasdaq: IGMS) is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. IgM antibodies have inherent properties that we believe may enable them to improve upon the efficacy and safety of IgG antibodies in multiple therapeutic applications. We have created a proprietary IgM antibody technology platform that we believe is particularly well suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Our lead product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3, and we have initiated a Phase 1 clinical trial for the treatment of relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL) patients in 2019. Our second product candidate is IGM-8444, an IgM antibody targeting Death Receptor 5 (DR5) for the treatment of patients with solid and hematologic malignancies, for which we have recently initiated a Phase 1 clinical trial. Also in our product pipeline is IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

Biotechnology

IGM Biosciences

IGM Biosciences' headquarters in Mountain View, CA, United States

This department oversees strategic direction and governance across the organization.

Leadership

The Leadership Team at IGM Biosciences oversees the strategic direction and operational management of the company, focusing on the development and commercialization of innovative IgM antibody therapies. Comprised of executive leaders from diverse backgrounds, the team guides research and development efforts, regulatory strategies, and market positioning, while ensuring alignment with the company's mission to advance treatments for various malignancies and autoimmune conditions. Additionally, they foster collaboration across departments to drive innovation and operational efficiency.

Leadership Team

The Executive Operations Team at IGM Biosciences is responsible for steering the strategic direction and overall operational management of the company. This team makes critical decisions related to company growth, financial planning, commercial strategies, human resources, business development, and manufacturing processes. They ensure that IGM Biosciences stays aligned with its mission to innovate and advance its proprietary IgM antibody technology platform, facilitating the development and clinical trials of its leading product candidates.

Executive Operations Team

This department focuses on conducting scientific research and developing innovative solutions.

Research and Development

The Scientific and Medical Team at IGM Biosciences is responsible for advancing the company's proprietary IgM antibody technology platform. This team, composed of experts in clinical development, strategy, scientific research, and medical oversight, leads the design and execution of clinical studies, oversees the progression of product candidates through early and late-stage clinical trials, and develops strategic initiatives for autoimmune, inflammation, and infectious disease applications. They also ensure rigorous scientific research and medical compliance throughout the product development lifecycle, aiming to innovate and improve therapeutic outcomes.

Scientific and Medical Team

The Senior VP team at IGM Biosciences consists of high-level executives overseeing various critical domains such as quality control, preclinical sciences, immuno-oncology, intellectual property, corporate accounting, and manufacturing operations. This team is responsible for strategic decision-making, ensuring operational excellence, advancing scientific research, managing intellectual assets, and overseeing financial and manufacturing activities to drive the company's mission of developing novel IgM antibody treatments.

��

People (7)

Jobs (0)

Other teams

Leadership Team

Executive Operations Team

Research and Development

Scientific and Medical Team

Senior VP

��������

People (7)

Jobs (0)

Other teams

Leadership Team

Executive Operations Team

Research and Development

Scientific and Medical Team

Senior VP

��